Silarus Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Silarus Therapeutics General Information

Description

Developer of therapeutic treatment designed to treat iron deficiency and iron overload disorders. The company's therapeutic treatment targets Erythroferrone which is a recently-discovered hormone that regulates the iron supply for red blood cell production, thereby enabling patients to begin treatment and result in a likelihood of a successful treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 290
  • La Jolla, CA 92037
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 11099 North Torrey Pines Road
  • Suite 290
  • La Jolla, CA 92037
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Silarus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Mar-2023 Completed Startup
2. Early Stage VC (Series A) 22-Sep-2014 Completed Startup
1. University Spin-Out 01-Jan-2014 Completed Startup
To view Silarus Therapeutics’s complete valuation and funding history, request access »

Silarus Therapeutics Patents

Silarus Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3519432-A1 Erfe fusion polypeptides compositions and methods of use Inactive 03-Oct-2016
US-20200040054-A1 Erfe fusion polypeptides compositions and methods of use Inactive 03-Oct-2016
EP-3497127-A1 Erfe specific antibodies compositions and methods of use Inactive 05-Aug-2016
US-20190284274-A1 Erfe specific antibodies compositions and methods of use Inactive 05-Aug-2016 C07K16/26

Silarus Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of California, Los Angeles University
To view Silarus Therapeutics’s complete investors history, request access »

Silarus Therapeutics FAQs

  • When was Silarus Therapeutics founded?

    Silarus Therapeutics was founded in 2014.

  • Where is Silarus Therapeutics headquartered?

    Silarus Therapeutics is headquartered in La Jolla, CA.

  • What industry is Silarus Therapeutics in?

    Silarus Therapeutics’s primary industry is Drug Discovery.

  • Is Silarus Therapeutics a private or public company?

    Silarus Therapeutics is a Private company.

  • What is Silarus Therapeutics’s current revenue?

    The current revenue for Silarus Therapeutics is .

  • How much funding has Silarus Therapeutics raised over time?

    Silarus Therapeutics has raised $10M.

  • Who are Silarus Therapeutics’s investors?

    University of California, Los Angeles has invested in Silarus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »